What does 95% COVID-19 vaccine efficacy really mean?
作者信息
Olliaro Piero
机构信息
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
出版信息
Lancet Infect Dis. 2021 Jun;21(6):769. doi: 10.1016/S1473-3099(21)00075-X. Epub 2021 Feb 17.
Abstract
摘要
相似文献
1
What does 95% COVID-19 vaccine efficacy really mean?95%的新冠疫苗效力究竟意味着什么？
Lancet Infect Dis. 2021 Jun;21(6):769. doi: 10.1016/S1473-3099(21)00075-X. Epub 2021 Feb 17.
2
Improving the Covid-19 Vaccination Rate in Pakistan-A Multipronged Policy Approach.提高巴基斯坦的新冠疫苗接种率——一种多管齐下的政策方法。
Front Public Health. 2021 Sep 3;9:729102. doi: 10.3389/fpubh.2021.729102. eCollection 2021.
3
Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.致编辑的信：母乳喂养与新冠疫苗：我们可以做到。
J Hum Lact. 2021 May;37(2):275-276. doi: 10.1177/08903344211004443. Epub 2021 Mar 16.
4
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
5
COVID-19 Vaccination in Pregnancy: The Benefits Outweigh the Risks.孕期接种新冠病毒疫苗：益处大于风险。
J Obstet Gynaecol Can. 2021 Jul;43(7):814-816. doi: 10.1016/j.jogc.2021.03.010.
6
"Let me choose my COVID-19 vaccine".让我选择我的新冠疫苗。
Eur J Intern Med. 2021 May;87:104-105. doi: 10.1016/j.ejim.2021.01.030. Epub 2021 Feb 4.
7
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.预防 COVID-19 疫苗接种和感染相关的 SARS-CoV-2 介导的嗜酸性疾病的策略。
Int Arch Allergy Immunol. 2020;181(8):624-628. doi: 10.1159/000509368. Epub 2020 Jun 16.
8
["Covid-19 vaccine obstacle course"].["新冠疫苗障碍赛道"]
Rev Prat. 2021 Apr;71(4):351.
9
[Current state of vaccination against SARS-CoV-2].[新型冠状病毒2型（SARS-CoV-2）疫苗接种的现状]
Z Rheumatol. 2021 Mar;80(2):158-164. doi: 10.1007/s00393-021-00966-9. Epub 2021 Feb 2.
10
The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated.选择的力量：关于选择新冠疫苗的自由会提高接种意愿的实验证据。
Eur J Intern Med. 2021 May;87:106-108. doi: 10.1016/j.ejim.2021.03.015. Epub 2021 Mar 19.
引用本文的文献
1
How Does Vaccine-Induced Immunity Compare to Infection-Acquired Immunity in the Dynamics of COVID-19?在新冠病毒病的动态变化中，疫苗诱导的免疫与感染获得的免疫相比如何？
Pathogens. 2025 Feb 11;14(2):179. doi: 10.3390/pathogens14020179.
2
COVID-19 Policy Response Analysis: A Canadian Perspective.COVID-19 政策应对分析：加拿大视角。
Int J Environ Res Public Health. 2024 Jun 17;21(6):787. doi: 10.3390/ijerph21060787.
3
Interplay of Digital Proximity App Use and SARS-CoV-2 Vaccine Uptake in Switzerland: Analysis of Two Population-Based Cohort Studies.数字近距离应用程序使用与瑞士 SARS-CoV-2 疫苗接种的相互作用：两项基于人群的队列研究分析。
Int J Public Health. 2023 Sep 20;68:1605812. doi: 10.3389/ijph.2023.1605812. eCollection 2023.
4
N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study.N-乙酰半胱氨酸作为住院新冠肺炎患者的辅助治疗：一项单中心前瞻性队列研究。
Caspian J Intern Med. 2023 Summer;14(3):543-552. doi: 10.22088/cjim.14.3.553.
5
Comparative mRNA booster effectiveness against death or hospitalization with COVID-19 pneumonia across at-risk US Veteran populations.比较有风险的美国退伍军人群体中，mRNA 加强针在预防 COVID-19 肺炎导致的死亡或住院方面的有效性。
Nat Commun. 2023 May 23;14(1):2976. doi: 10.1038/s41467-023-38503-8.
6
Illusion of knowledge in statistics among clinicians: evaluating the alignment between objective accuracy and subjective confidence, an online survey.临床医生在统计学方面的知识错觉：评估客观准确性和主观置信度之间的一致性，一项在线调查。
Cogn Res Princ Implic. 2023 Apr 20;8(1):23. doi: 10.1186/s41235-023-00474-1.
7
Public Perception towards Vaccines as Preventive Measures against a Twindemic (Seasonal Influenza and COVID-19): A Cross-Sectional Study from the Aseer Region, Saudi Arabia.公众对作为预防双流行（季节性流感和新冠疫情）措施的疫苗的认知：沙特阿拉伯阿西尔地区的一项横断面研究
Vaccines (Basel). 2023 Feb 28;11(3):558. doi: 10.3390/vaccines11030558.
8
Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy.相对风险降低率：临床试验及新冠疫苗效力中的误导性指标。
Dialogues Health. 2022 Dec;1:100074. doi: 10.1016/j.dialog.2022.100074. Epub 2022 Nov 10.
9
Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines.与目前已获授权的新冠疫苗相关的比较益处和风险。
Vaccines (Basel). 2022 Dec 1;10(12):2065. doi: 10.3390/vaccines10122065.
10
Communicating about COVID-19 vaccine development and safety.关于 COVID-19 疫苗研发和安全性的沟通。
PLoS One. 2022 Aug 5;17(8):e0272426. doi: 10.1371/journal.pone.0272426. eCollection 2022.
Zotero 插件